Evaluation of the efficiency of using Salmonella Kentucky and Escherichia coli O119 bacteriophages in the treatment and prevention of salmonellosis and colibacillosis in broiler chickens.

Phage therapy is considered an alternative modality in the treatment of different bacterial diseases. However, their therapeutic and preventive roles against infections caused by S.Kentucky and E.coli O119 were of little attention. In this study, two phages were isolated, characterized, and assessed for their potential therapeutic and preventive roles against S.Kentucky and E.coli O119 infections in broilers. Commercial one-day-old arboacres broiler chicks were assigned to seven groups: Group Ӏ was as a negative control, groups (П and Ш) were assigned as positive controls by the challenge of S.Kentucky and E.coli O119, respectively. The remaining four groups (IV, V, VI, and VII) were administrated with five repeated phage doses to determine the effect of multiple doses. Phages were administrated in groups (IV and VI) after challenging with S.Kentucky and E.coli O119, respectively to assess their therapeutic role; moreover, their preventive role was evaluated through administration in groups (V and VII) before challenging with S.Kentucky and E.coli O119, respectively. Sampling was done from different organs at three-time points and revealed that phage treated groups had lower colony-forming units of S.Kentucky and E.coli. Our results suggest that bacteriophages are efficient in the treatment and prevention of salmonellosis and colibacillosis in broiler farms. This article is protected by copyright. All rights reserved.